1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Oral Drug Delivery Market
4. Executive Summary
5. Voice of Customer
6. Global Oral Drug
Delivery Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
6.2.2. By Type (Controlled Release, Orodispersible Tablets,
Others)
6.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology,
Gastrointestinal, Respiratory, Cardiovascular, Others)
6.2.4. By End User (Hospitals, Ambulatory Surgical Centres,
Diagnostic Centres, Clinics, Others)
6.2.5. By Company
6.2.6. By Region
6.3. Product Market Map
7. North America
Continuous Oral Drug Delivery Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Formulation
7.2.2. By Type
7.2.3. By Therapy Area
7.2.4. By End User
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States Oral
Drug Delivery Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Formulation
7.3.1.2.2.
By Type
7.3.1.2.3.
By Therapy Area
7.3.2. Canada Oral Drug Delivery
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Formulation
7.3.2.2.2.
By Type
7.3.2.2.3.
By Therapy Area
7.3.3. Mexico Oral Drug
Delivery Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Formulation
7.3.3.2.2.
By Type
7.3.3.2.3.
By Therapy Area
8. Europe Oral Drug
Delivery Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Formulation
8.2.2. By Type
8.2.3. By Therapy Area
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country
Analysis
8.3.1. France Oral Drug
Delivery Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Formulation
8.3.1.2.2.
By Type
8.3.1.2.3.
By Therapy Area
8.3.2. Germany Oral Drug
Delivery Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Formulation
8.3.2.2.2.
By Type
8.3.2.2.3.
By Therapy Area
8.3.3. United Kingdom Oral
Drug Delivery Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Formulation
8.3.3.2.2.
By Type
8.3.3.2.3.
By Therapy Area
8.3.4. Italy Oral Drug
Delivery Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Formulation
8.3.4.2.2.
By Type
8.3.4.2.3.
By Therapy Area
8.3.5. Spain Oral Drug
Delivery Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Formulation
8.3.5.2.2.
By Type
8.3.5.2.3.
By Therapy Area
9. Asia-Pacific Oral
Drug Delivery Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Formulation
9.2.2. By Type
9.2.3. By Therapy Area
9.2.4. By End User
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Oral Drug
Delivery Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Formulation
9.3.1.2.2.
By Type
9.3.1.2.3.
By Therapy Area
9.3.2. India Oral Drug Delivery
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Formulation
9.3.2.2.2.
By Type
9.3.2.2.3.
By Therapy Area
9.3.3. Japan Oral Drug
Delivery Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Formulation
9.3.3.2.2.
By Type
9.3.3.2.3.
By Therapy Area
9.3.4. South Korea Oral
Drug Delivery Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Formulation
9.3.4.2.2.
By Type
9.3.4.2.3.
By Therapy Area
9.3.5. Australia Oral Drug
Delivery Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Formulation
9.3.5.2.2.
By Type
9.3.5.2.3.
By Therapy Area
10.
Middle East and Africa Oral Drug Delivery Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Formulation
10.2.2. By Type
10.2.3. By Therapy Area
10.2.4. By End User
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Oral Drug
Delivery Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Formulation
10.3.1.2.2.
By Type
10.3.1.2.3.
By Therapy Area
10.3.2. Saudi Arabia Oral
Drug Delivery Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Formulation
10.3.2.2.2.
By Type
10.3.2.2.3.
By Therapy Area
10.3.3. UAE Oral Drug
Delivery Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Formulation
10.3.3.2.2.
By Type
10.3.3.2.3.
By Therapy Area
11.
South America Oral Drug Delivery Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Formulation
11.2.2. By Type
11.2.3. By Therapy Area
11.2.4. By End User
11.2.5. By Country
11.3.
South America: Country Analysis
11.3.1. Brazil Oral Drug
Delivery Market Outlook
11.3.1.1. Market Size &
Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share &
Forecast
11.3.1.2.1.
By Formulation
11.3.1.2.2.
By Type
11.3.1.2.3.
By Therapy Area
11.3.2. Argentina Oral Drug
Delivery Market Outlook
11.3.2.1. Market Size &
Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share &
Forecast
11.3.2.2.1.
By Formulation
11.3.2.2.2.
By Type
11.3.2.2.3.
By Therapy Area
11.3.3. Colombia Oral Drug
Delivery Market Outlook
11.3.3.1. Market Size &
Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share &
Forecast
11.3.3.2.1.
By Formulation
11.3.3.2.2.
By Type
11.3.3.2.3.
By Therapy Area
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Competition Outlook
14.2.
Company Profiles
14.2.1.
Novartis AG
14.2.2.
Biocon Ltd.
14.2.3.
NovoNordisk A/S
14.2.4.
F.Hoffmann-La Roche Ltd.
14.2.5.
Bayer AG
14.2.6.
Emishphere Technologies Inc.
14.2.7.
Enteris Biopharma Inc.
14.2.8.
Merrion Pharmaceuticals Plc.
14.2.9.
Amgen Inc.
14.2.10.
Pfizer Inc.
15. Strategic Recommendations
(Note:
The companies list can be customized based on the client requirements.)
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com